New York-Potential suitors are lining up to express interest in the probable sale of Pfizer Inc.'s surgical ophthalmology business, but so far, no one is proposing-publicly.
Lindus Health announces “All-in-One Ophthalmology CRO”
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Researchers detail acute angle closure glaucoma attack in patient with Hermansky-Pudlak syndrome
Advancing the optimal diagnosis & treatment of thyroid eye disease
Merck and EyeBio announce initiation of phase 2b/3 BRUNELLO trial evaluating MK-3000 for treatment of diabetic macular edema
Ocuphire Pharma doses first patient in phase 3 VEGA-3 clinical trial